The US Food and Drug Administration (FDA) has approved a cranial electrotherapy stimulator (Cervella, Innovative Neurological Devices) for treatment of anxiety, depression, and insomnia, the company has announced.
Cervella, which requires a prescription, delivers micro pulses of electrical current across the brain, which in clinical trials led to a reduction in anxiety levels, insomnia, and depressed mood, the company said in a news release.
Cervella is the first cranial electrotherapy stimulator (CES) with proprietary conductive treatment electrodes that have been seamlessly integrated into noise-cancelling, Bluetooth-enabled headphones, the company said.
Click here to read the full article.
